Ulrike Beisiegel | Academic Influence

Ulrike Beisiegel's AcademicInfluence.com Rankings

Ulrike Beisiegel

Biology

#952

World Rank

#1660

Historical Rank

Molecular Biology

#172

World Rank

#176

Historical Rank

Biochemistry

#367

World Rank

#440

Historical Rank

biology Degrees

Download Badge

Biology

Ulrike Beisiegel's Degrees

PhD Biochemistry University of Göttingen

Why Is Ulrike Beisiegel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ulrike Beisiegel is a German biochemist and university professor who in 2011 became the first woman to serve as president of the University of Göttingen, founded in 1737. Her research on liver fats and disease was honored with the Heinz Maier-Leibnitz Prize, the Rudolf Schönheimer Medal and an honorary doctorate. Intent on maintaining high levels of scholarship and diminishing scientific misconduct, she has served on many boards and committees, receiving the Ubbo-Emmius Medal for her commitment to good scientific practice and an honorary doctorate from the University of Edinburgh.

(See a Problem?)

Ulrike Beisiegel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein (1989) (661)
Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. (1991) (581)
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. (1989) (456)
Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. (2007) (387)
A highly effective, nontoxic T1 MR contrast agent based on ultrasmall PEGylated iron oxide nanoparticles. (2009) (353)
Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. (1982) (309)
Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia. (1981) (284)
A rapid micromethod for apolipoprotein E phenotyping directly in serum. (1987) (279)
Characterization of four lipoprotein classes in human cerebrospinal fluid. (2001) (273)
Genetics of the apolipoprotein E system in man. (1980) (267)
Antioxidant and prooxidant activity of alpha-tocopherol in human plasma and low density lipoprotein. (1996) (220)
Surface distribution and recycling of the low density lipoprotein receptor as visualized with antireceptor antibodies (1982) (212)
Increased lipoprotein oxidation in Alzheimer's disease. (2000) (204)
The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. (1993) (173)
Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma (2001) (171)
Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. (1979) (170)
The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. (1993) (164)
Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. (2009) (163)
Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia: evidence that simvastatin affects cholesterol metabolism in the human brain. (2002) (161)
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. (2000) (155)
Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA. (1990) (145)
Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease (2002) (141)
Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. (1997) (135)
An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. (1979) (131)
Impaired Recycling of Apolipoprotein E4 Is Associated with Intracellular Cholesterol Accumulation* (2004) (131)
Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of α-carotene and γ-tocopherol (1999) (129)
Immunoblot analysis of low density lipoprotein receptors in fibroblasts from subjects with familial hypercholesterolemia. (1982) (123)
Rapid angiographic progression of coronary artery disease in patients with elevated lipoprotein(a) (1995) (122)
Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis. (2005) (122)
Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease. (2001) (120)
Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). (1996) (119)
VLDL receptor mediates the uptake of human chylomicron remnants in vitro. (1996) (114)
Annexin VI Stimulates Endocytosis and Is Involved in the Trafficking of Low Density Lipoprotein to the Prelysosomal Compartment* (2000) (112)
Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. (1997) (112)
Lipoprotein (a) in the arterial wall (1991) (108)
Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation. (1996) (108)
Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication (2004) (104)
Cholesterol Modulates the Membrane Binding and Intracellular Distribution of Annexin 6* (2002) (100)
Interaction of the lipoprotein lipase asparagine 291-->serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. (1995) (99)
Recycling of Apoprotein E Is Associated with Cholesterol Efflux and High Density Lipoprotein Internalization* (2003) (94)
The Human Factor H-related Protein 4 (FHR-4) (1997) (92)
Insulin stimulates hepatic low density lipoprotein receptor-related protein 1 (LRP1) to increase postprandial lipoprotein clearance. (2009) (89)
Receptors for triglyceride-rich lipoproteins and their role in lipoprotein metabolism (1995) (88)
Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters. (1991) (82)
Acute-Phase Serum Amyloid A as a Marker of Insulin Resistance in Mice (2008) (82)
Expression of LRP1 by Human Osteoblasts: A Mechanism for the Delivery of Lipoproteins and Vitamin K1 to Bone (2004) (82)
A carboxyl-terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor-related protein and inhibits lipase-mediated uptake of lipoprotein in cells. (1994) (82)
Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease (2012) (81)
Intracellular processing of endocytosed triglyceride-rich lipoproteins comprises both recycling and degradation. (1999) (80)
New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis. (1996) (78)
Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic Watanabe rabbits. (2002) (78)
Endothelial-derived lipoprotein lipase is bound to postprandial triglyceride-rich lipoproteins and mediates their hepatic clearance in vivo (2002) (77)
Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein. (1995) (76)
Lipoprotein lipase mediates an increase in the selective uptake of high density lipoprotein-associated cholesteryl esters by hepatic cells in culture. (1998) (75)
Recycling of Apolipoprotein E and Lipoprotein Lipase through Endosomal Compartments in Vivo * (2001) (73)
How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper. (1998) (73)
Annexin VI, a marker protein of hepatocytic endosomes. (1994) (72)
Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. (1988) (70)
Apolipoprotein E Polymorphism and Serum Concentration in Alzheimer's Disease in Nine European Centres: the ApoEurope Study (2000) (69)
Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins. (1996) (69)
Low density lipoprotein oxidizability by copper correlates to its initial ubiquinol‐10 and polyunsaturated fatty acid content (1994) (67)
Frequency of and interaction between polymorphisms in the β3-adrenergic receptor and in uncoupling proteins 1 and 2 and obesity in Germans (2000) (67)
Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro. (1999) (65)
Unequal crossing-over between two alu-repetitive DNA sequences in the low-density-lipoprotein-receptor gene. A possible mechanism for the defect in a patient with familial hypercholesterolaemia. (1987) (64)
Knockdown of Hepatic ABCA1 by RNA Interference Decreases Plasma HDL Cholesterol Levels and Influences Postprandial Lipemia in Mice (2005) (64)
Apolipoprotein E‐binding Proteins Isolated from Dog and Human Liver (1988) (64)
Lipid binding of apolipoprotein CII is required for stimulation of lipoprotein lipase activity against apolipoprotein CII-deficient chylomicrons. (1997) (64)
Structural features in lipoprotein lipase necessary for the mediation of lipoprotein uptake into cells. (1995) (61)
Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. (2001) (61)
Donor splice site mutation in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo C-II deficiency. (1988) (59)
Oxidatively modified human low-density lipoprotein stimulates leukocyte adherence to the microvascular endothelium in vivo (1991) (59)
Mechanisms of lipid peroxidation in human blood plasma: a kinetic approach. (1997) (58)
Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor gamma (PPAR gamma) gene and type 2 diabetes. (2001) (58)
Dietary Fish Oil Reduces Leukocyte/Endothelium Interaction Following Systemic Administration of Oxidatively Modified Low Density Lipoprotein (1991) (58)
Chylomicron remnant metabolism. Role of hepatic lipoprotein receptors in mediating uptake. (1989) (57)
Lack of association between a human β-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity (1999) (57)
Does Gastric Restriction Surgery Reduce the Risks of Metabolic Diseases? (1998) (57)
Measurement of oxidizability of blood plasma. (1999) (57)
FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene (2005) (57)
How different constituents of low density lipoprotein determine its oxidizability by copper: a correlational approach. (1996) (52)
Histological Changes in the Liver of Morbidly Obese Patients: Correlation with Metabolic Parameters (2005) (51)
Immunologic cross-reactivity of the low density lipoprotein receptor from bovine adrenal cortex, human fibroblasts, canine liver and adrenal gland, and rat liver. (1981) (50)
Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. (1997) (48)
Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol. (1999) (47)
Apolipoprotein E isoforms and rare mutations: parallel reduction in binding to cells and to heparin reflects severity of associated type III hyperlipoproteinemia. (1995) (46)
Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study. (1997) (45)
MED-PED: An Integrated Genetic Strategy for Preventing Early Deaths (1996) (45)
CSF-tau, CSF-Aß1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer’s disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity (2003) (43)
Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. (1998) (42)
Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia (1986) (42)
Extraction of lipoprotein(a), apo B, and apo E from fresh human arterial wall and atherosclerotic plaques. (1995) (41)
The Effect of Loss of Excess Weight on the Metabolic Risk Factors after Bariatric Surgery in Morbidly and Super-Obese Patients (2007) (41)
Lipoprotein lipase (EC 3.1.1.34) targeting of lipoproteins to receptors (1997) (41)
Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits. (2002) (38)
Whole plasma oxidation assay as a measure of lipoprotein oxidizability (1997) (37)
Receptor-Mediated Uptake in the Liver (1986) (37)
Depression in Alzheimer’s Disease Might Be Associated with Apolipoprotein E ε4 Allele Frequency in Women but Not in Men (2002) (35)
Correlation of apolipoprotein(a) isoproteins with Lp(a) density and distribution in fasting plasma. (1992) (35)
Apo(a) phenotypes and Lp(a) concentrations in offspring of men with and without myocardial infarction. The EARS Study. European Atherosclerosis Research Study. (1995) (34)
What do all the apolipoprotein E receptors do? (1997) (32)
Variation in the gene for human peroxisome proliferator activated receptor γ (PPARγ) does not play a major role in the development of morbid obesity (2000) (32)
Time-course of oxidation of lipids in human cerebrospinal fluid in vitro (2000) (31)
The Role of α2M Receptor/LRP in Chylomicron Remnant Metabolism (1994) (31)
Increased Lipid Peroxidation in Cerebrospinal Fluid and Plasma from Patients with Creutzfeldt–Jakob Disease (2002) (30)
Apolipoprotein E and lipoprotein lipase co‐ordinately enhance binding and uptake of chylomicrons by human hepatocytes (1995) (29)
Patterns of oxidized epitopes, but not NF-kappa B expression, change during atherogenesis in WHHL rabbits. (2003) (28)
A polymorphism, L162V, in the peroxisome proliferator-activated receptor α (PPARα) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus (2001) (27)
Characterization of lipid metabolism in insulin-sensitive adipocytes differentiated from immortalized human mesenchymal stem cells. (2008) (26)
Apolipoprotein C‐ll deficiency syndrome due to apo C‐IIHamburg: clinical and biochemical features and Hphl restriction enzyme polymorphism (1992) (26)
Recurrent missense mutations at the first and second base of codon Arg243 in human lipoprotein lipase in patients of different ancestries (1994) (26)
An emerging understanding of the interactions of plasma lipoproteins with the arterial wall that leads to the development of atherosclerosis. (1996) (25)
The effect of pharmacological doses of different antioxidants on oxidation parameters and atherogenesis in hyperlipidaemic rabbits. (2001) (25)
Association between polymorphisms in candidate genes and morbid obesity (2001) (25)
Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia (1998) (25)
Delayed low density lipoprotein (LDL) catabolism despite a functional intact LDL-apolipoprotein B particle and LDL-receptor in a subject with clinical homozygous familial hypercholesterolemia. (1998) (23)
Recycling of apolipoprotein E is not associated with cholesterol efflux in neuronal cells. (2008) (22)
Research integrity and publication ethics. (2010) (22)
Nonphysiological overexpression of low-density lipoprotein receptors causes pathological intracellular lipid accumulation and the formation of cholesterol and cholesteryl ester crystals in vitro (1999) (21)
α- and β-Carotenes in low density lipoprotein are the preferred target for nitric oxide-induced oxidation (2000) (21)
Renal handling of human apolipoprotein(a) and its fragments in the rat. (2001) (21)
Differential RNA interference: replacement of endogenous with recombinant low density lipoprotein receptor-related protein (LRP). (2004) (20)
Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients. (1991) (20)
Lipoprotein lipase compensates for the defective function of apo E variants in vitro by interacting with proteoglycans and lipoprotein receptors. (1999) (20)
In vivo removal of beta-VLDL, chylomicron remnants, and alpha 2-macroglobulin in the rat. (1993) (19)
Different mobility in SDS—polyacrylamide gel electrophoresis of apolipoprotein E from phenotypes Apo E‐N and Apo E‐D (1979) (19)
Immunocytochemical differential diagnosis of adrenocortical neoplasms using the monoclonal antibody D11 (2005) (18)
Plasma triglycerides after oral glucose load specifically associate with metabolic risk markers in healthy type 2 diabetes offspring. (2011) (18)
Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men. (2002) (18)
Lipoprotein metabolism. (1998) (18)
Investigation of the influence of two low-dose monophasic oral contraceptives containing 20 micrograms ethinylestradiol/75 micrograms gestodene and 30 micrograms ethinylestradiol/75 micrograms gestodene, on lipid metabolism in an open randomized trial. (1996) (17)
SEVERE TANGIER DISEASE WITH A NOVEL ABCA1 GENE MUTATION (2008) (16)
Liver TAG Transiently Decreases While PL n-3 and n-6 Fatty Acids are Persistently Elevated in Insulin Resistant Mice (2008) (16)
Molecular genetics of apoC-II and lipoprotein lipase deficiency. (1991) (15)
Lipoproteins and apolipoproteins in human pleural effusions. (1992) (15)
Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries (2005) (15)
Fatty acids and gene expression. (2003) (14)
Antibody against low density lipoprotein receptor blocks uptake of low density lipoprotein (but not high density lipoprotein) by the adrenal gland of the mouse in vivo. (1981) (14)
Comparison of Metabolic Risk Factors between Severely and Very Severely Obese Patients (2006) (14)
Charge‐shift electrophoresis of apolipoproteins from normal humans and patients with tangier disease (1979) (14)
ApoE-genotype and clinical parameters in the diagnosis of Alzheimer ’ s disease : combination of CSF-tau and MMSE yields highest sensitivity and specificity (2003) (13)
Lipids and lipoproteins in the brain. (2001) (13)
Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits (2004) (12)
Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries (2005) (12)
-Tocopherol as a Reductant for Cu(II) in Human Lipoproteins (1996) (12)
The role of alpha 2M receptor/LRP in chylomicron remnant metabolism. (1994) (12)
[Lipid peroxidation as a common pathomechanism in coronary heart disease and Alzheimer disease]. (2001) (11)
Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonate. (1990) (11)
Compound heterozygosity for a new (S259G) and a previously described (G188E) mutation in lipoprotein lipase (LpL) as a cause of chylomicronemia. Mutations in brief no. 183. Online. (1998) (11)
Variation in the gene for human peroxisome proliferator activated receptor gamma (PPARgamma) does not play a major role in the development of morbid obesity. (2000) (11)
Sensory and Metabolic Control of Energy Balance (2010) (10)
Use of vitamin C and E in the treatment of Alzheimer's disease (2002) (10)
Physical properties of oxidized lipoproteins. (1995) (10)
The role of lipases and LRP in the catabolism of triglyceride-rich lipoproteins. (1996) (9)
Stewards of Integrity: Institutional Approaches to Promote and Safeguard Good Research Practice in Europe (2008) (9)
Alpha- and beta-carotenes in low density lipoprotein are the preferred target for nitric oxide-induced oxidation. (2000) (8)
Bone: a forgotten organ in lipidology? (2002) (8)
A Question of Integrity (2008) (7)
[Motivation of young academics for medical research. Position of the German Council of Science and Humanities]. (2009) (6)
Investigation into the role of the hormone sensitive lipase -60C>G promoter variant in morbid obesity. (2005) (6)
Upregulated synthesis of both apolipoprotein A-I and apolipoprotein B in familial hyperalphalipoproteinemia and hyperbetalipoproteinemia. (1998) (5)
Therapeutic dose of HIV-1 protease inhibitor saquinavir does not permanently influence early insulin signaling. (2004) (5)
Receptor-Mediated Endocytosis and Intracellular Trafficking of Lipoproteins (2009) (4)
A sensitive noninvasive method for monitoring successful liver-directed gene transfer of the low-density lipoprotein receptor in Watanabe hyperlipidemic rabbits in vivo (2004) (3)
Lovastatin versus bezafibrate: effects on lipoproteins and urinary mevalonate (1992) (2)
Getting to grips with biomedical fraud and misconduct Frank Wells Michael (2009) (2)
Family study in familial hypercholesterolemia with a receptor-negative homozygous 9-year-old boy. (1986) (2)
In vitro mutagenesis studies defining residues of lipoprotein lipase critical for mediation of the binding of lipoproteins to the LDL receptor-related protein (LRP) (1994) (2)
Molecular characterization of a colony of cats with lipoprotein lipase deficiency (LPL) reveals a mutation that impairs catalytic activity and interaction with the LDL receptor-related protein (LRP) (1994) (2)
3.P.27 Physiological doses of chemically different antioxidants decrease the oxidizability of blood plasma in hyperlipidaemic rabbits (1997) (2)
Lipid peroxidation in neurodegeneration: new insights into (2002) (1)
Abstract: P656 POSTPRANDIAL LIPOPROTEINS STIMULATE THE RELEASE OF PROINFLAMMATORY CYTOKINES IN HUMAN ADIPOCYTES (2009) (1)
Low-density lipoprotein receptors. (1991) (1)
Meeting Summary Ninth Annual European Lipoprotein Conference (2005) (1)
Interaction of the lipoprotein lipase ASN291 -> SER mutation with body mass index in determining elevated plasma lipid concentrations in hyperlipidaemic subjects, myocardial infarction survivors and healthy controls (1995) (1)
Antiatherosclerotic effect of probucol in WHHL rabbits: Are there plasma parameters to evaluate this effect? (2005) (1)
Lipoprotein lipase can compensate for the defective function of apolipoprotein E variants in lipoprotein binding to cells (1994) (1)
Treatment of severe hypercholesterolemia and coronary heart disease by simvastatin and LDL apheresis (HELP)-effects on coronary lesions (1992) (1)
Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease (2012) (1)
Discussing honesty, diligence and education (2011) (1)
[Regulation of the remnant receptor]. (1990) (1)
[New knowledge of the pathogenesis of familial hypercholesterolemia]. (1986) (1)
Apoprotein recycling of triglyceride-rich lipoproteins: A process controlled by exogenous HDL (1999) (1)
Time-course of Oxidation of Human Cerebrospinal Fluid Lipids in In Vitro (2000) (1)
Antiatherosclerotic effect of probucol in WHHL rabbits: are there plasma parameters to evaluate this effect? (2011) (1)
2.P.149 Uptake of lipoprotein(a) by mouse embryonic fibroblasts via the LDL-receptor and/or the LDL receptor-related protein (1997) (1)
Th-P15:70 Insulin stimulates the recycling of apolipoprotein E via the low density lipoprotein receptor-related protein 1 (LRP1) (2006) (1)
[Hypertriglyceridemia and arteriosclerosis. Physiology and pathophysiology of chylomicron catabolism]. (1995) (1)
Annexins in endocytosis. (1996) (1)
PO1-6 INSULIN STIMULATES THE HEPATIC LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 (LRP1) IN VIVO (2007) (1)
Tangier disease with syringomyelia-like phenotype in a family from Afghanistan caused by a novel mutation in the ABCA1 gene (2006) (1)
[Cholesterol in pleural effusions: a differential diagnostic aid]. (1990) (1)
Liver-specific overexpression of lysosomal acid lipase in transgenic mice (2001) (0)
Abstract: P1196 DISTINCT PLASMA FATTY ACID PATTERNS ASSOCIATE WITH INSULIN RESISTANCE AND COMPONENTS OF THE METABOLIC SYNDROME IN HEALTHY OFFSPRING OF TYPE 2 DIABETES PATIENTS (2009) (0)
Intracellular trafficking — Consequence of receptor mediated uptake of lipoproteins (2000) (0)
Mo-W11:1 New molecular mechanism in the regulation of postprandial lipemia (2006) (0)
T06-P-009 The influence of insulin on the postprandial metabolism of apolipoprotein E (2005) (0)
3.P.10 Different antioxidants divergently affect the extent of atherosclerosis and oxycholesterol levels in homozygous WHHL rabbits (1997) (0)
NON-INVASIVE IN VIVO IMAGING OF RECOMBINANT POSTPRANDIAL LIPOPROTEINS LABELLED WITH NANOCRYSTALS (2008) (0)
YI-790 INSULIN AND CHOLESTEROL DEPENDENT EXPRESSION OF PROTEINS REGULATING LIPOPROTEIN METABOLISM AND INSULIN SIGNALLING IN HEPATOCYTES (2007) (0)
Hepatic lipase mediates lipoprotein uptake into cells via LDL receptor-related protein (1995) (0)
W13.326 APOE recycling is preceded by storage in large LRP-positive vesicles (2004) (0)
Current Status on the Apo E-Receptor (1989) (0)
In Vitro Studies on Human Chylomicron Catabolism (1996) (0)
W16 HIGH SPEED INTRAVITAL MICROSCOPY VISUALIZES THE UPTAKE OF NANOCRYSTALS-LABELLED TRIGLYCERIDE-RICH LIPOPROTEINS IN STELLATE CELLS IN VIVO (2010) (0)
Cell receptors : morphological characterization and pathological aspects (1990) (0)
W10-IS-002 HDL-induced recycling of apo E is connected to cholesterol efflux (2005) (0)
Responsibility of scientists (1988) (0)
Monoclonal Antibody as a Probe for Structural and Functional Studies of the LDL Receptor (1983) (0)
The recycling of apo E represents a new intracellular link between HDL and TRL metabolism (2001) (0)
SUBSTANTIAL ALTERATIONS IN LIPID METABOLISM OCCUR EARLY IN THE DEVELOPMENT OF INSULIN RESISTANCE IN MICE AS REVEALED BY METABOLIC PROFILING (2008) (0)
P298 DISTINCT PLASMA FATTY ACIDS ASSOCIATE WITH COMPONENTS OF THE METABOLIC SYNDROME IN HEALTHY OFFSPRING OF TYPE 2 DIABETES PATIENTS (2010) (0)
Increased oxidative stress in diabetic patients as a risk factor for atherosclerosis (1999) (0)
Plasma Lipid Dynamics After Oral Glucose Versus Oral Fat Load Are Differently Associated With Metabolic Risk Factors (2010) (0)
The Collections, Museums and Gardens of Göttingen University (2015) (0)
PO12-324 THE ROLE OF THE LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 (LRP1) FOR THE RECYCLING OF APOLIPOPROTEIN E (2007) (0)
Lipoproteins labbeld with quantum dots: New tools for in vitro and in vivo experiments (2006) (0)
FATTY ACIDS GENERATED BY LIPOPROTEIN LIPASE STIMULATE THE EXPRESSION OF PROINFLAMMATORY CYTOKINES IN HUMAN ADIPOCYTES (2008) (0)
Endosomal and extraendosomal intracellular trafficking of lipoproteins (1994) (0)
W08-P-024 A human adipocyte cell system as a tool to study cellular lipid metabolism (2005) (0)
The Molecular Basis of ApoC-II Deficiency (1989) (0)
W10.272 Influence of polyunsaturated fatty acids on the proteome of human hepatoma cells (2004) (0)
Changes in serum levels of fetal antigen 1 (FA1/Pref-1/Dlk1) in extreme nutritional states (2009) (0)
Tu-P7:4 A new human adipocyte cell system to study energy metabolism (2006) (0)
3P-0755 Replacement of endogenous with recombinant LRP using differential RNA interference (2003) (0)
Atherosclerosis:Cell biology and lipoproteins:Editorial comment (1990) (0)
P261 HEPATIC LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 (LRP1) INCREASES CHYLOMICRON REMNANT UPTAKE BY TWO MECHANISMS (2010) (0)
Unregulated overexpression of LDL receptors in hepatoma cells results in pathological lipid accumulation (1999) (0)
Original Contribution INCREASED LIPOPROTEIN OXIDATION IN ALZHEIMER’S DISEASE (2010) (0)
Th-P15:6 Lipoproteins labelled with fluorescent and superparamagnetic nanocrystals: New tools for in vitro and in vivo experiments (2006) (0)
Lipoproteins labelled with fluorescent Nanoparticles: New tools for the visualisation of intracellular pathways. (2007) (0)
A Membrane Fluidizing Factor in Sera from Duchenne Muscular Dystrophy Patients: Effect on Lymphocyte Membranes of Incubation in Patient and Control Lipoproteins (1989) (0)
Lipoprotein uptake in mouse fibroblasts lacking the LDL receptor, the LRP or both (1995) (0)
Using nanosomes for ex vivo detection of atherosclerotic lesions in apolipoprotein E knockout mice by fluorescence imaging (2011) (0)
TRIGLYCERIDE-RICH LIPOPROTEINS INFLUENCES ADIPOCYTOKINE SECRETION IN HUMAN ADIPOCYTES (2007) (0)
Role of Rab5 and Annexin VI in endocytosis and intracellular transport of low density lipoproteins (1999) (0)
The binding region of lipoprotein lipase to LDL receptor-related protein (1994) (0)
80 Physiological doses of chemically different antioxidants decrease the plasma level of oxidized cholesterols in hyperlipidaemic rabbits (1997) (0)
Sterol regulation of human LDL receptor expression in gene therapy (2000) (0)
Th-P15:125 Diet induced obesity in C57BL/6 mice is associated with substantial alterations in fatty acid composition in different organs and plasma lipoproteins (2006) (0)
P310 CHOLESTEROL- AND FATTY-ACID-PROFILES IN SUBJECTS WITH IRON OVERLOAD AND IRON DEFICIENCY ANEMIA (2010) (0)
W10-P-014 Knockdown of hepatic ABCA1 decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice (2005) (0)
Apolipoprotein E concentration and polymorphism in relation with triglycerides in six European countries: The ApoEurope Project (2000) (0)
W13.326 APOE recycling is preceded by storage in large LRP-positive vesicles (2004) (0)
A NOVEL HUMAN HEPATIC CELL MODEL FOR POSTPRANDIAL LIPOPROTEIN METABOLISM (2008) (0)
W13.333 Expression of LRP1 by human osteoblast-like cells: A mechanism for the delivery of dietary vitamin K to bone (2004) (0)
MS5 THE HAMBURG STUDY – A PROSPECTIVE OBSERVATION OF 2000 HEALTHY WORKERS TO STUDY THE DEVELOPMENT OF THE METABOLIC SYNDROME (2010) (0)
Receptor Mediated Hepatic Uptake of Lipoproteins (1993) (0)
W13.325 Apolipoprotein A-V accelerates catabolism of triglyceride-rich lipoproteins in vivo (2004) (0)
Cholesterol disbalance at neuromuscular junctions and CNS synapses: a unifying cause of degeneration (2019) (0)
P213 ENDOGENOUS APOLIPOPROTEIN E REGULATES ADIPOGENIC DIFFERENTIATION (2010) (0)
1.P.124 The role of variation in the lipoprotein lipase (LpL) gene in the development of type III hyperlipoproteinamia (1997) (0)
Lipoprotein lipase (LpL) polymorphisms and response to therapy in patients attending a lipid clinic (2001) (0)
Oxidizability of human plasma correlates with its radical-trapping ability and with the oxidizability of plasma low density lipoprotein (1995) (0)
78 The incidence of C-T substitution at −480 of the hepatic lipase (HL) promoter in patients with mixed hyperlipidemia (1997) (0)
Receptor Regulation of Lipoprotein Metabolism (1992) (0)
MS44 A DECREASE OF PLASMA TRIACYLGLYCEROL AFTER ORAL GLUCOSE LOAD PREDICTS LOWER METABOLIC RISK (2010) (0)
PO15-405 DIETARY INDUCED IRON OVERLOAD DIMINISHES THE ENDOTHELIUM-DEPENDENT RELAXATION IN RATS (2007) (0)
Abstract: 549 NEW ASPECTS OF POSTPRANDIAL LIPID METABOLISM (2009) (0)
W13.332 Uptake of chylomicron remnants into murine bone marrow in vivo (2004) (0)
The LDL Receptor in Lipoprotein Turnover (1984) (0)
Fatty Liver Disease in Morbidly Obese Patients in Correlation to Obesity Related Co-Morbidities (2005) (0)
PO1-15 INSULIN SENSITIVITY IN A NOVEL HUMAN ADIPOCYTE CELL MODEL (2007) (0)
Insulin-stimulated translocation of LDL receptor-related protein 1 facilitates hepatic endocytosis of lipoproteins (2007) (0)
Lipoprotein metabolism and membrane receptors (1984) (0)
Abstract: 140 REAL-TIME MAGNETIC RESONANCE IMAGING AND QUANTIFICATION OF LIPOPROTEIN METABOLISM IN VIVO USING NANOCRYSTALS (2009) (0)
52 Acute effects of heparin on triglyceride —, apolipoprotein E — and lipoprotein lipase levels in humans (1997) (0)
P8 SYNTHESIS, PHYSICOCHEMICAL AND TOXICOLOGICAL CHARACTERIZATION OF 59FE-LABELLED NANOPARTICLES FOR TARGETING ARTERIOSCLEROTIC LESIONS (2010) (0)
LIPID AND LIPOPROTEIN UPTAKE INTO HUMAN ADIPOCYTES IN VITRO (2008) (0)
1WS03-5 Recycling of apoprotein E promotes cholesterol-efflux and generation of HDL-E (2003) (0)
Sudden hearing loss is associated with low levels of lipoprotein (a) (2000) (0)
Chapter 5. Tissue-Lipoprotein Interactions: Lipoprotein Receptors (1989) (0)
PO20-611 IMPACT OF ARGININE/CITRULLINE SUPPLEMENTATION ON INSULIN RESISTANCE IN DIO MICE (2007) (0)
Non-invasive in vivo imaging of recombinant Lipoproteins labelled with nanocrystals (2007) (0)
2.W18.1 Cellular metabolism of triglyceride-rich lipoproteins (1997) (0)
11 MEMBRANE TOXICITY OF DUCHENNE MUSCULAR DYSTROPHY (DMD) SERUM IS LIPOPROTEIN‐BOUND (1988) (0)
Protein blotting (0)
Role of lipases and LDL receptor-related protein in human chylomicron remnant catabolism (1994) (0)

This paper list is powered by the following services:

Other Resources About Ulrike Beisiegel

en.wikipedia.org

What Schools Are Affiliated With Ulrike Beisiegel?

Ulrike Beisiegel is affiliated with the following schools:

Image Attributions

Image Source for Ulrike Beisiegel